Institute for Medical Sciences, Ajou University School of Medicine, Suwon, 443-749, Korea.
J Cell Sci. 2011 Feb 15;124(Pt 4):647-56. doi: 10.1242/jcs.075770. Epub 2011 Jan 25.
The current paradigm of noncanonical NF-κB signaling suggests that the loss of TRAF2, TRAF3 or cIAP1 and cIAP2 leads to stabilization of NF-κB-inducing kinase (NIK) to activate the noncanonical pathway. Although a crucial role of RIP1 in the TNFα-induced canonical NF-κB pathway has been well established, its involvement in noncanonical activation of NF-κB through the TNFR1 receptor, is unknown. Here we show that TNFα is capable of activating the noncanonical NF-κB pathway, but that activation of this pathway is negatively regulated by RIP1. In the absence of RIP1, TNFR1 stimulation leads to activation of the noncanonical NF-κB pathway through TRAF2 degradation, leading to NIK stabilization, IKKα phosphorylation and the processing of p100 to generate p52. Thus although RIP1(-/-) mouse embryonic fibroblasts are sensitive at early time points to cell death induced by TNFα, probably as a result of lack of canonical NF-κB activation, the late activation of the noncanonical NF-κB pathway protects the remaining cells from further cell death. The TNFR1-dependent noncanonical NF-κB activation in RIP1(-/-) cells suggests that there is functional interplay between the two NF-κB pathways during TNFR1 signaling, which might regulate the number and kinds of NF-κB transcription factors and thus finely control NF-κB-dependent gene transcription.
目前的非典型 NF-κB 信号转导模式表明,TRAF2、TRAF3 或 cIAP1 和 cIAP2 的缺失会导致 NF-κB 诱导激酶 (NIK) 的稳定,从而激活非典型途径。虽然 RIP1 在 TNFα 诱导的经典 NF-κB 途径中起着至关重要的作用,但它在 TNFR1 受体介导的非典型 NF-κB 激活中的作用尚不清楚。在这里,我们表明 TNFα 能够激活非典型 NF-κB 途径,但该途径的激活受到 RIP1 的负调控。在没有 RIP1 的情况下,TNFR1 刺激会通过 TRAF2 的降解导致非典型 NF-κB 途径的激活,导致 NIK 稳定、IKKα 磷酸化以及 p100 的加工生成 p52。因此,尽管 RIP1(-/-) 鼠胚胎成纤维细胞在早期对 TNFα 诱导的细胞死亡很敏感,可能是由于缺乏经典 NF-κB 激活,但非典型 NF-κB 途径的晚期激活可防止剩余细胞进一步死亡。在 RIP1(-/-) 细胞中,TNFR1 依赖性非典型 NF-κB 激活表明在 TNFR1 信号转导过程中,两种 NF-κB 途径之间存在功能相互作用,这可能调节 NF-κB 转录因子的数量和种类,从而精细地控制 NF-κB 依赖性基因转录。
J Recept Signal Transduct Res. 2010-4
Biochemistry. 2008-1-8
Sci STKE. 2006-10-17
Front Immunol. 2025-4-30
Cancers (Basel). 2023-2-18
Front Cell Dev Biol. 2022-5-23
Clin Transl Med. 2021-11
Front Immunol. 2020